Published in Cancer Weekly, July 1st, 2008
"Ceap-16 and BRD7 interacted with each other both in vitro and in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.